Exhibit 32.2

                           CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Samaritan Pharmaceuticals,
Inc. (the "Company") on Form 10-Q for the quarter ended March 31, 2006 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), the undersigned, in the capacities and on the dates indicated below,
hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge: 1. The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and 2. The information contained in the Report
fairly presents, in all material respects, the financial condition and results
of operation of the Company.

Date  May 15, 2006                               By:     /s/ Eugene Boyle
                                                         -----------------
                                                 Name:   Eugene Boyle
                                                 Title:  Chief Financial Officer





A signed original of this written statement required by Section 906, or other
document authentications, acknowledging, or otherwise adopting the signature
that appears in typed form within the electronic version of this written
statement required by Section 906, has been provided to Samaritan
Pharmaceuticals, Inc. and will be retained by Samaritan Pharmaceuticals, Inc.
and furnished to the Securities and Exchange Commission or its staff upon
request.